rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17
Income
Operating income 599.55 433.42 424.16 294.66 215.84
Expenses
Material consumed 337.91 243.03 236.34 169.35 112.37
Manufacturing expenses 10.90 8.95 8.22 7.02 6.90
Personnel expenses 54.64 48.51 46.33 45.86 39.77
Selling expenses - - - - -
Adminstrative expenses 82.38 61.43 69.94 43.29 32.30
Expenses capitalised - - - - -
Cost of sales 485.84 361.93 360.83 265.52 191.35
Operating profit 113.71 71.49 63.33 29.15 24.49
Other recurring income 31.16 0.17 7.93 7.43 6.95
Adjusted PBDIT 144.87 71.66 71.26 36.57 31.44
Financial expenses 5.34 7.29 6.56 7.67 4.49
Depreciation 15.19 11.64 8.69 12.25 15.00
Other write offs - - - - -
Adjusted PBT 124.33 52.73 56.01 16.65 11.95
Tax charges 25.95 14.82 12.39 4.23 0.40
Adjusted PAT 98.38 37.90 43.62 12.43 11.55
Non recurring items -0.20 0.16 0.03 0.12 -0.01
Other non cash adjustments - - - - -
Reported net profit 98.19 38.07 43.65 12.55 11.54
Earnigs before appropriation 65.50 -24.67 -60.69 -100.88 -106.02
Equity dividend 4.09 2.47 2.05 2.46 5.91
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 61.41 -27.14 -62.74 -103.34 -111.93

Mutual Fund Selector

Find the fund that is right for you
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close